The DECISION-CTO Extended 10 Y Follow-up
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
The goal of this clinical trial is to compare long term efficacy of drug-eluting stent implantation compare to optimal medical treatment in patient with chronic total occlusion in a very long-term follow-up (minimum 10 years) period.
Eligibility criteria
Qualifiers
Clinical 1) Patients with angina or silent ischemia and documented ischemia 2) Patients who are eligible for intracoronary stenting 3) Age >18 years
Angiographic 1) De novo lesion Chronic Total Occlusion (CTO) 2) Reference vessel size ≥ 2.5 mm by visual estimation 3) At least one CTO lesions located in proximal or mid epicardial coronary artery.
CTO definition: TIMI (Thrombolysis in Myocardial Infarction) flow 0 or 1 with estimated duration over 3 months
The duration of the occlusion was determined by the interval from the last episode of acute coronary syndrome, or
Disqualifiers
History of bleeding diathesis or coagulopathy
Pregnant state
Three vessel CTOs
Known hypersensitivity or contra-indication to contrast agent and heparin
Trial design
Treatments tested in this trial
- Not listed
Trial groups
840 Participants
are grouped into 1 trial groupLocations
19India
Ruby Hall Clinic411001, PuneMaharashtra, India
Indonesia
Medistra Hospital12950, JakartaDKI Jakarta, Indonesia
South Korea
SAM hospital Anyang South Korea
Soon Chun Hyang University Hospital Bucheon Bucheon-si South Korea
Sponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
Source ClinicalTrials.gov